RY 167.72 0.9449% SHOP 138.14 2.8363% TD 88.13 0.8237% ENB 64.29 -0.1863% BN 76.87 2.6439% TRI 253.97 -1.1982% CNQ 39.95 -0.125% CP 103.18 2.5035% CNR 138.0 4.2454% BMO 134.78 1.133% BNS 69.45 0.6522% CSU 5024.1851 0.7628% CM 88.0 0.7787% MFC 43.615 2.1429% ATD 71.18 2.1527% NGT 70.8 -0.6455% TRP 69.43 0.202% SU 49.85 0.8701% WCN 271.53 -0.0331% L 222.41 -0.6433%
Company Overview: Global Atomic Corporation (TSX: GLO) is a diversified Canadian-based company operating through its subsidiaries, with activities spanning both the zinc recycling and uranium exploration sectors. Lineage Cell Therapeutics, Inc. (NYSE: LCTX) is a clinical-stage biotechnology company focused on the development of allogeneic (donor-derived) cell therapies aimed at treating serious neurological and ophthalmic disorders. The Report covers the Price Action, Technical Indicators Analysis along with the Stop Loss Levels, Target Prices, and Recommendations on these two stocks.
Global Markets Wrap-Up
As of May 1, 2025, major U.S. equity benchmarks delivered solid week-to-date (WTD) gains, driven by widespread buying across sectors. The S&P 500 advanced 1.43%, finishing the week at 5,604.14, while the NASDAQ Composite outperformed with a 1.89% gain, closing at 17,710.74, bolstered by strong momentum in the technology sector. In contrast, the Russell 2000, which tracks small-cap stocks, posted a more modest 0.93% WTD rise, ending at 1,975.86, underperforming relative to its large-cap counterparts.
In Canada, the S&P/TSX Venture Composite Index (TSX: ^JX) registered a 1.17% WTD gain, closing the week at 646.15, as of May 1. While the index continued its broader downward trend, Thursday’s session saw pockets of strength emerge in the healthcare, financials, and real estate sectors, offering some relief. However, the upside was capped by continued weakness in technology, consumer cyclicals, basic materials, industrials, energy, and consumer non-cyclicals, which weighed heavily on overall market sentiment.
Xxxxxx Xxxxxx Xxxxxx
Xxxxxx Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Xxxxxx Xxxxxx Xxxxxx Xxxxxx & Xxxxxx
Xxxxxx Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Enter your details below and our team will help you to decide if this product is best for you.
The advice given by Kalkine Canada Advisory Services Inc. and provided on this website is general information only and it does not take into account your investment objectives, financial situation and the particular needs of any particular person. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. The website www.kalkine.ca is published by Kalkine Canada Advisory Services Inc. The link to our Terms & Conditions has been provided please go through them. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.
CA
NZ
UK
US
AU
IND
Please wait processing your request...